60 likes | 386 Views
TORPEDO TRIAL. T hrombus O bliteration by R apid P ercutaneous E ndovenous Intervention in D eep Venous O cclusion “TORPEDO” trial : Mid –Term results Mohsen Sharifi,MD,FACC, Mahshid Mehdipour, Curt Bay, PhD, Gary Smith,MD, Jalaladdin Sharifi,MD
E N D
TORPEDO TRIAL Thrombus Obliteration by Rapid Percutaneous Endovenous Intervention in Deep Venous Occlusion “TORPEDO” trial : Mid –Term results Mohsen Sharifi,MD,FACC, Mahshid Mehdipour, Curt Bay, PhD, Gary Smith,MD, Jalaladdin Sharifi,MD Arizona Cardiovascular Consultants & A.T. Still University, Mesa, AZ
TORPEDO TRIAL First Randomized trial Evaluating Reduction of DVT Sequelae with Percutaneous Endovenous Intervention (PEVI)
183 Randomized Control No=92 PEVI No=91 8 pts Control 81 PEVI 88 F/U at 30±5months
TORPEDO TRIAL Primary endpoints Post- thrombotic Syndrome Recurrent Venous Thromboembolic Disease Secondary Endpoints • Skin Induration • Leg Edema • Hospital Stay • Subjective Perception of Improvement • Bleeding
ConclusionsPEVI + anticoagulation is superior to anticoagulation alone in: • Reduction of recurrent VTE. • Reduction of PTS • Reduction of hospital stay • Reduction of leg edema • Reduction of skin induration • Reduction in duration of parenteral anticoagulants • Subjective perception of improvement